Adocia
Records under this name other than the patents Adocia holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 29 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,426,382 | Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative Lapsed on the fee record Ended Apr 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | From the USPTO record |
| US 8,389,661 | Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs Lapsed on the fee record Ended Mar 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 5, 2025 | From the USPTO record |
| US 8,367,640 | Complex consisted of a polysaccharide and an HBP Lapsed on the fee record Ended Feb 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | From the USPTO record |
| US 9,457,089 | Highly concentrated aqueous protein solution with reduced viscosity Lapsed on the fee record Ended Oct 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2024 | From the USPTO record |
| US 10,525,133 | Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof Lapsed on the fee record Ended Jan 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2024 | From the USPTO record |
| US 10,485,851 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid Lapsed on the fee record Ended Nov 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2023 | From the USPTO record |
| US 10,449,256 | Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer Lapsed on the fee record Ended Oct 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2023 | From the USPTO record |
| US 9,115,218 | Anionic polysaccharides functionalized by at least two hydrophobic groups carried by an at least trivalent spacer Lapsed on the fee record Ended Aug 25, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 25, 2023 | From the USPTO record |
| US 10,383,918 | Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acid Lapsed on the fee record Ended Aug 20, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2023 | From the USPTO record |
| US 9,089,476 | Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5 Lapsed on the fee record Ended Jul 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 28, 2023 | From the USPTO record |